Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer.

Raoof S, Mulford IJ, Frisco-Cabanos H, Nangia V, Timonina D, Labrot E, Hafeez N, Bilton SJ, Drier Y, Ji F, Greenberg M, Williams A, Kattermann K, Damon L, Sovath S, Rakiec DP, Korn JM, Ruddy DA, Benes CH, Hammerman PS, Piotrowska Z, Sequist LV, Niederst MJ, Barretina J, Engelman JA, Hata AN.

Oncogene. 2019 Sep;38(37):6399-6413. doi: 10.1038/s41388-019-0887-2. Epub 2019 Jul 19.

PMID:
31324888
2.

KRAS G12C NSCLC Models Are Sensitive to Direct Targeting of KRAS in Combination with PI3K Inhibition.

Misale S, Fatherree JP, Cortez E, Li C, Bilton S, Timonina D, Myers DT, Lee D, Gomez-Caraballo M, Greenberg M, Nangia V, Greninger P, Egan RK, McClanaghan J, Stein GT, Murchie E, Zarrinkar PP, Janes MR, Li LS, Liu Y, Hata AN, Benes CH.

Clin Cancer Res. 2019 Jan 15;25(2):796-807. doi: 10.1158/1078-0432.CCR-18-0368. Epub 2018 Oct 16.

PMID:
30327306
3.

Exploiting MCL1 Dependency with Combination MEK + MCL1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in KRAS-Mutant Non-Small Cell Lung Cancer.

Nangia V, Siddiqui FM, Caenepeel S, Timonina D, Bilton SJ, Phan N, Gomez-Caraballo M, Archibald HL, Li C, Fraser C, Rigas D, Vajda K, Ferris LA, Lanuti M, Wright CD, Raskin KA, Cahill DP, Shin JH, Keyes C, Sequist LV, Piotrowska Z, Farago AF, Azzoli CG, Gainor JF, Sarosiek KA, Brown SP, Coxon A, Benes CH, Hughes PE, Hata AN.

Cancer Discov. 2018 Dec;8(12):1598-1613. doi: 10.1158/2159-8290.CD-18-0277. Epub 2018 Sep 25.

4.

A Case of Neonatal Marfan Syndrome: A Management Conundrum and the Role of a Multidisciplinary Team.

Carande EJ, Bilton SJ, Adwani S.

Case Rep Pediatr. 2017;2017:8952428. doi: 10.1155/2017/8952428. Epub 2017 Jan 11.

5.

Proton versus conventional radiotherapy for pediatric salivary gland tumors: Acute toxicity and dosimetric characteristics.

Grant SR, Grosshans DR, Bilton SD, Garcia JA, Amin M, Chambers MS, McGovern SL, McAleer MF, Morrison WH, Huh WW, Kupferman ME, Mahajan A.

Radiother Oncol. 2015 Aug;116(2):309-15. doi: 10.1016/j.radonc.2015.07.022. Epub 2015 Jul 28.

6.

Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma.

Gomez DR, Hong DS, Allen PK, Welsh JS, Mehran RJ, Tsao AS, Liao Z, Bilton SD, Komaki R, Rice DC.

J Thorac Oncol. 2013 Feb;8(2):238-45. doi: 10.1097/JTO.0b013e31827740f0.

7.

Use of a deformable atlas to identify cryptic critical structures in the treatment of glioblastoma multiforme.

Weksberg DC, Bilton SD, Chang EL.

PLoS One. 2012;7(3):e32098. doi: 10.1371/journal.pone.0032098. Epub 2012 Mar 26.

8.

Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery.

Pinnix CC, Fontanilla HP, Hayes-Jordan A, Subbiah V, Bilton SD, Chang EL, Grosshans DR, McAleer MF, Sulman EP, Woo SY, Anderson P, Green HL, Mahajan A.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):317-26. doi: 10.1016/j.ijrobp.2011.06.1985. Epub 2011 Nov 19.

9.

Consequences of anatomic changes and respiratory motion on radiation dose distributions in conformal radiotherapy for locally advanced non-small-cell lung cancer.

Britton KR, Starkschall G, Liu H, Chang JY, Bilton S, Ezhil M, John-Baptiste S, Kantor M, Cox JD, Komaki R, Mohan R.

Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):94-102. doi: 10.1016/j.ijrobp.2008.04.016. Epub 2008 Oct 17.

PMID:
18929448
10.

Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.

Chang JY, Zhang X, Wang X, Kang Y, Riley B, Bilton S, Mohan R, Komaki R, Cox JD.

Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1087-96. Epub 2006 May 6.

PMID:
16682145
11.

Elastic image mapping for 4-D dose estimation in thoracic radiotherapy.

Guerrero T, Zhang G, Segars W, Huang TC, Bilton S, Ibbott G, Dong L, Forster K, Lin KP.

Radiat Prot Dosimetry. 2005;115(1-4):497-502.

PMID:
16381774
12.

Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?

Lee CT, Bilton SD, Famiglietti RM, Riley BA, Mahajan A, Chang EL, Maor MH, Woo SY, Cox JD, Smith AR.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):362-72.

PMID:
16168831
13.

Assessment of consistency in contouring of normal-tissue anatomic structures.

Collier DC, Burnett SS, Amin M, Bilton S, Brooks C, Ryan A, Roniger D, Tran D, Starkschall G.

J Appl Clin Med Phys. 2003 Winter;4(1):17-24.

14.

Isoseparation curves: a mechanism for optimizing off-axis dose homogeneity of intact breast irradiation.

Buchholz TA, Bilton S, Gurgoze E, Strom EA, McNeese MD, Bice WS, Prestidge BR.

Radiat Oncol Investig. 1998;6(4):191-8.

PMID:
9727879
15.

Low contrast charts effectively differentiate between types of blur.

Ho A, Bilton SM.

Am J Optom Physiol Opt. 1986 Mar;63(3):202-8.

PMID:
3963143

Supplemental Content

Loading ...
Support Center